Supernus Pharmaceuticals, Inc. (Supernus) and Sage Therapeutics, Inc. (Sage) announced a definitive agreement for Supernus to acquire Sage for $975 million. With the deal, Supernus will acquire the rights to Sage Therapeutics’ oral treatment for postpartum depression, Zurzuvae, which it developed with Biogen. According to the announcement, Zurzuvae is the only oral medication approved by the U.S. Food and Drug Administration (FDA) to treat postpartum depression. The transaction is expected to close in the third quarter of 2025.;

In an investor presentation about the deal, Supernus stated that the U.S. Centers for Disease Control and Prevention estimates . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

Mergers & Acquisitions

2020 and 2021 saw record numbers of mergers, acquisitions, affiliations, and partnerships and this raises the strategic question for any executive team of a specialty provider organization, do they have market positioning for a sustainable future and can they address that issue with changes in scale. Almost every executive team is considering collaborations to keep their competitive advantage. It’s imperative to find out if those collaborations were successful in improving competitive advantage, as well as the “tricks of the trade” in making collaboration work.


Outpatient care, specialty services, and cost containment solutions are projected to drive merger and acquisition activity in the health care sector during 2026, according to a recent report by VMG Health. Increased deal volume is projected for physician practices, behavioral health, home-based care, and ambulatory surgery centers. Technology, including artificial intelligence (AI), is being used to strengthen diagnostics, automation, and workflow optimization, is emerging as a differentiator in health care mergers and acquisitions, particularly in… Read